Immune checkpoint inhibitors (ICI) can achieve durable responses in patients with advanced melanoma, and results from clinical trials suggest cure may be possible for a subset of patients. Despite cli…

Read more about 'Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma'...

Posted in Research; Posted 9 months ago 2 Minute(s) to read